Project Grant HT94252510405
Award Date
6/1/25
Completion Date
5/31/29
Dollars Obligated
$986K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The University of Pittsburgh - Of The Commonwealth System of Higher Education was awarded a $1,572,933 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support advanced biomedical research initiatives focused on exploring lysosomal pathways to improve host immunity following coronavirus infections. The 4-year project, with a start date of January 1, 2025 and end date of December 31, 2028, aims...
The University of Alabama at Birmingham (UAB) has been awarded a $6,459,464.00 Project Grant from the Defense Health Agency to evaluate pirfenidone, a novel therapeutic strategy against recurrent acute pancreatitis. The award, which runs from Sep 1, 2023 to Aug 31, 2027, is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research to transform healthcare for Service Members...
This $1,971,628 Project Grant awarded by the Defense Health Agency on May 15, 2024 will fund research at the University of Washington to investigate the "Mechanisms of Activin Signaling in Acute Pancreatitis" over a 4-year period ending on May 14, 2028. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research initiatives aimed at improving health outcomes for military service members,...
The U.S. Department of Defense's Defense Health Agency awarded a $384,000 Project Grant to the Cold Spring Harbor Laboratory (CSHL) to study the impact of recurrent acute pancreatitis on macrophage heterogeneity and function. This grant, awarded under the Military Medical Research and Development program (CFDA 12.420), will fund research aimed at improving the health and care of military service members, veterans, and their families. The grant has a performance period from February 1, 2024 to...
The federal Project Grant award of $2,674,057.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to Cedars-Sinai Medical Center in West Hollywood, CA. The grant will fund research to identify pathways of progression from acute pancreatitis to recurring acute pancreatitis and chronic pancreatitis over the award period from June 1, 2025 to May 31, 2029. The research conducted by Cedars-Sinai Medical Center, a prominent academic...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award of $4,902,315.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Pittsburgh to understand the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. The research project will be conducted over a 4-year period from June 1, 2025 to May 31, 2029. The University of Pittsburgh, a major public research university, has...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
The Trustees of the University of Pennsylvania were awarded a $560,870 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...